Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zynrelef for Postoperative Pain in Robot Assisted Total Knee Arthroplasty
NCT07430085Phase 4Recruiting
- Sponsor
- Allegheny Singer Research Institute
- Start
- Sep 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine, meloxicam, sponsored by Allegheny Singer Research Institute. Started Sep 2026; status: recruiting.
02
Drugs
bupivacainemeloxicam
Beyond the preview
Go deeper on NCT07430085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07430085.